iifl-logo

Jenburkt Pharmaceuticals Ltd AGM

1,322.85
(-1.45%)
Jul 25, 2025|12:00:00 AM

Jenburkt Pharma CORPORATE ACTIONS

26/07/2024calendar-icon
26/07/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM18 Jul 202520 May 2025
To schedule the Companys 40th Annual General Meeting on Friday, 18 July 2025 to be held by Video Conferencing / Other Audio-Visual Means (VC/OAVM). Submission of the Annual Report for the FY 2024-25, containing Audited Financial Statements, Auditors Report and Directors Report and the Notice convening 40th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 20/06/2025) Newspaper publication in pursuance of Rule 20(4) of the companies (Management and Administration) Rules, 2014, in connection with the 40th AGM of the Company. (As Per BSE Announcement Dated on 23.06.2025) Summary of the proceedings of the 40th Annual General Meeting of the Company held on 18th July, 2025. Submission of Consolidated Voting Results and Scrutinizers Report on all the resolutions as set out in the notice convening the 40th AGM of the Company held on 18th July, 2025. Appointment of Secretarial Auditor of the Company. Proceedings of the 40th Annual General Meeting of the Company held on today i.e. 18th July, 2025. (As per BSE Announcement Dated on 18/07/2025)
AGM30 Jul 202428 May 2024
Outcome of Board Meeting Held on 28th May, 2024 Intimation of Book Closure date and Cut-off Date for the purpose of Payment of Dividend and Remote e-voting for 39th Annual General Meeting. (As Per BSE Announcement dated on 28.05.2024) Proceedings of the 39th Annual General Meeting held on Toady i.e. 30th July, 2024. (As per BSE Announcement Dated on 30/07/2024) Submission of Voting Results and Scrutinizer report for the 39th AGM of the Company held on 30th July, 2024. (As Per BSE Announcement Dated on: 31/07/2024)

Jenburkt Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.